Niagen Bioscience, Inc. Income Statement
NAGE|15 years of annual SEC 10-K data (FY2011-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 15 fiscal years. All figures from audited SEC 10-K filings.
Niagen Bioscience, Inc. reported $129M in revenue and $17M in net income for FY2025. Revenue has grown at a 22.5% compound annual rate over the past 14 years.
Based on SEC 10-K filings.
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $129.4M | $83.6M | $72.0M | $67.4M | $59.3M | $46.3M | $46.3M | $21.2M | $21.2M | $21.7M | $17.9M | $15.3M | $11.6M | $8.1M | $7.6M |
| Cost of Revenue | $46.2M | $32.8M | $29.3M | $26.0M | $24.0M | $20.5M | $20.5M | $10.7M | $10.7M | $11.3M | $10.4M | $10.0M | $9.3M | $5.6M | $4.6M |
| Gross Profit | $83.2M | $50.8M | $42.8M | $41.5M | $35.3M | $25.8M | $25.8M | $10.5M | $10.5M | $10.4M | $7.5M | $5.3M | $2.3M | $2.5M | $2.9M |
| SG&A Expense | $27.1M | $25.0M | $28.3M | $36.4M | $30.8M | $34.3M | $34.3M | $17.6M | $17.6M | $9.2M | $7.2M | $7.9M | $8.4M | $7.8M | $3.9M |
| R&D Expense | $6.3M | $5.0M | $4.8M | $3.8M | $3.4M | $4.4M | $4.4M | $4.0M | $4.0M | $2.5M | $891.6K | $513.7K | $142.0K | $96.8K | - |
| Operating Income | $16.3M | -$5.6M | -$18.6M | -$27.1M | -$19.9M | -$31.3M | -$31.3M | -$16.4M | -$16.4M | -$2.9M | -$2.1M | -$5.2M | -$11.6M | -$7.9M | -$2.0M |
| Interest Expense | - | - | $3.0K | -$55.0K | $71.0K | $847.0K | $847.0K | $153.0K | $153.0K | $333.3K | $566.9K | $158.8K | $29.0K | -$32.1K | $36.1K |
| Income Tax | $810.0K | $0 | - | - | - | - | - | - | $0 | $0 | -$4.5K | $0 | - | - | - |
| Net Income | $17.4M | -$4.9M | -$16.5M | -$27.1M | -$19.9M | -$32.1M | -$32.1M | -$11.4M | -$11.4M | -$2.9M | -$2.8M | -$5.4M | -$11.7M | -$7.9M | -$2.1M |
| EPS (Basic) | $0.11 | -$0.07 | -$0.24 | -$0.40 | -$0.33 | - | - | - | $0.05 | $0.01 | - | - | - | - | - |
| EPS (Diluted) | $0.11 | -$0.07 | -$0.24 | -$0.40 | -$0.33 | -$0.56 | -$0.61 | -$0.26 | $0.04 | $0.01 | -$0.04 | -$0.04 | -$0.13 | -$0.12 | -$0.04 |
| Shares Outstanding | 77.3M | 75.0M | 74.6M | 68.1M | 61.9M | 59.6M | 55.1K | 54.7M | 37.5M | 36.0M | 105.3M | 104.5M | 92.1M | 72.9M | 60.9M |
| Gross Margin | 64.3% | 60.8% | 59.4% | 61.5% | 59.5% | 55.7% | 55.7% | 49.4% | 49.4% | 48.0% | 42.1% | 34.8% | 19.6% | 30.5% | 38.9% |
| Operating Margin | 12.6% | -6.7% | -25.9% | -40.1% | -33.5% | -67.6% | -67.6% | -77.3% | -77.3% | -13.4% | -11.6% | -34.2% | -100.2% | -96.9% | -26.7% |
| Profit Margin | 13.4% | -5.9% | -23.0% | -40.2% | -33.6% | -69.5% | -69.5% | -53.7% | -53.7% | -13.5% | -15.5% | -35.2% | -100.4% | -97.3% | -27.1% |